Pharmaceutical companies are operating in increasingly complex markets, where forecasting accuracy, evolving therapy landscapes, and changing patient needs influence commercial decisions. Traditional forecasting models alone are becoming insufficient to anticipate market shifts and assess future opportunities. Advanced analytics, artificial intelligence, and real-world evidence are opening new ways for organizations to improve planning and make more informed strategic decisions.
AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma, organized by Marcus Evans, will take place on November 16–17, 2026, in London, United Kingdom. The two-day conference will bring together senior pharmaceutical professionals working across forecasting, commercial strategy, analytics, and artificial intelligence to explore how these capabilities can strengthen decision-making across the industry.
From Traditional Forecasting to AI-Driven Strategic Foresight
The conference will examine how pharmaceutical organizations can move beyond conventional forecasting approaches by integrating Generative AI, Agentic AI, and Real-World Evidence into their planning processes. Discussions will explore how Agentic AI can support evidence generation, while advanced analytics can improve forecasting confidence, commercial responsiveness, and long-term strategic planning.
Rare disease forecasting and lifecycle management are also central themes. Sessions will examine how integrated data and patient-centric insights can improve forecasting in specialized therapy markets, alongside approaches for managing uncertainty in volatile and high-growth therapeutic areas.
The program will further address scenario planning, healthcare data governance, and analytical integrity. Through expert-led panels, case studies, roundtable discussions, and interactive workshops, participants will explore how pharmaceutical companies can establish shared governance models and integrate forecasting, analytics, and AI capabilities across their organizations.
Pharma Leaders Bringing Forecasting and Analytics Perspectives
The announced speakers include Alireza Moayyeri, Senior Director, RWE Global at UCB, and Paul Boutry, Head of Strategic Planning & Analytics at BioMarin.
Also featured are Gerardo Martinez, Senior Director, Global Market Access – Pipeline (Immunology & Rare Diseases) at CSL, and Christopher Meyer, Head of Strategy & Operational Excellence at Ferring Pharmaceuticals. Their expertise spans real-world evidence, strategic planning, market access, and organizational strategy, bringing different perspectives to the challenges shaping pharmaceutical forecasting and analytics.
Explore the official agenda and speaker lineup here.
For pharmaceutical forecasting leaders, commercial strategists, analytics professionals, market access executives, and AI decision-makers, the conference offers an opportunity to examine how emerging technologies and stronger evidence-based planning can support more confident business decisions.
To know more about the event, agenda, and registration, visit the official Marcus Evans conference website.




